cyclen has been researched along with triazacyclononane in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruchertseifer, F; Morgenstern, A; Notni, J; Schwaiger, M; Seidl, C; Wester, HJ; Wurzer, A | 1 |
| Andres, J; Borbas, KE; Kiraev, SR; Kovacs, D; Mathieu, E; Tomar, M; Wells, JAL | 1 |
2 other study(ies) available for cyclen and triazacyclononane
| Article | Year |
|---|---|
Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.
Topics: Animals; Aza Compounds; Chelating Agents; Cyclams; Dipeptides; Heterocyclic Compounds; Heterografts; Humans; Male; Mice, SCID; Neoplasm Transplantation; Phosphatidylinositol Phosphates; Phosphinic Acids; Piperidines; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Structure-Activity Relationship | 2018 |
Improved emission of Yb(III) ions in triazacyclononane-based macrocyclic ligands compared to cyclen-based ones.
Topics: Cyclams; Ions; Lanthanoid Series Elements; Ligands | 2022 |